Developing core indicators of age-friendly cities: A global pilot project
Methods: A new approach developed through research and expert consultation identifies a set of core indicators measuring key aspects of the physical and social environment, as well as quality of life and equity. A pilot study was conducted with 15 communities from around the world to test the feasibility and utility of the core indicators, as described in a user's guide.
Results: Each site reported data on the core indicators and locally identified indicators, analyzing the usefulness of the data and providing feedback. While data availability for the core indicators varied across pilot sites, the pilot results validated the indicator set and its relevance as a monitoring framework for age-friendly cities and communities worldwide.
Conclusion: The core indicators provide an adaptable framework for measuring how well urban environments support the health and wellbeing of older adults. The indicator framework and user's guide are recommended for all cities and communities seeking to measure and improve the physical and social environments in response to, or in anticipation of, an ageing population.
Learning Areas:Conduct evaluation related to programs, research, and other areas of practice
Social and behavioral sciences
Explain the process by which core indicators of Age-friendly Cities was developed. Define the set of core indicators. Compare availability of indicator data across 15 communities in different countries from around the world which piloted the core indicators.
Keyword(s): Aging, International Health
Qualified on the content I am responsible for because: I have been the co-investigator on the WHO's Age Friendly Cities Indicators project, along with my colleague Dr. Megumi Kano who previously submitted this abstract. I have been engaged with leading this project for the last year, after previously serving on the WHO's reseach team investigating Innovations for Healthy Ageing.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.